Apr 13, 2016
1:3
For every 3 shares held, investors received 1.
The split itself did not change the total investment value.
Niagen Bioscience, Inc. (GETTEX:OCD1) operates in the Pharmaceuticals: other industry.
Niagen Bioscience, Inc. company overviewNiagen Bioscience, Inc.'s most recent stock split was on April 13, 2016. It was a 1-for-3 reverse split, so shareholders received 1 share for every 3 they held.
Niagen Bioscience, Inc. (GETTEX:OCD1) has split its stock 2 times: a 173-for-15 split on March 28, 2008 and a 1-for-3 reverse split on April 13, 2016.
Niagen Bioscience, Inc. has split its stock 2 times. This history records 2 splits between March 28, 2008 and April 13, 2016.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Niagen Bioscience, Inc.'s 1-for-3 reverse split on April 13, 2016, every 3 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Niagen Bioscience, Inc. has not announced a new split in our records. Its most recent split was on April 13, 2016, 10 years ago. Companies announce splits in advance, and any new GETTEX:OCD1 split will appear on this page.